Taiwan FDA registration 212ef526b3b922663924e968fae8622f
Ebil pertussis Bordebacterium IgA antibody test group
TW: 艾必爾百日咳博德氏桿菌IgA抗體測試組
Taiwan·Risk Class 1·IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH·Registered Apr 27, 2007 – Apr 27, 2012CancelledRegistration details
- Analysis ID
- 212ef526b3b922663924e968fae8622f
- Customs Code
- DHA04400580202
Company information
- Manufacturer Country
- Germany
- Authorized Representative
- Ariel Health Inc
Product details
- Intended Use
- Limited to the first level identification range of the Measures for the Administration of Medical Devices "Serum Reagent of C. Bordei (C.3065)".
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3065 博德氏桿菌屬血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Apr 27, 2007
- Expiry Date
- Apr 27, 2012
- Cancellation Date
- Apr 16, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Ebil pertussis Bordebacterium IgA antibody test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 212ef526b3b922663924e968fae8622f and manufactured by IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH. The authorized representative in Taiwan is Ariel Health Inc.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices